ロード中...
Cost-effectiveness of Transplanting HCV-Infected Livers into Uninfected Recipients with Preemptive Antiviral Therapy
BACKGROUND & AIMS: Guidelines do not recommend transplanting hepatitis C virus (HCV)-infected livers into HCV-uninfected recipients. Direct-acting antivirals (DAAs) can be used to treat donor-derived HCV infection. However the added cost of DAA therapy is a barrier. We evaluated the cost effecti...
保存先:
| 出版年: | Clin Gastroenterol Hepatol |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6382534/ https://ncbi.nlm.nih.gov/pubmed/30138735 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2018.08.042 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|